Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1995;91:1588-1595

This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morillo, C. A.
Right arrow Articles by Guiraudon, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morillo, C. A.
Right arrow Articles by Guiraudon, C. M.

(Circulation. 1995;91:1588-1595.)
© 1995 American Heart Association, Inc.


Articles

Chronic Rapid Atrial Pacing

Structural, Functional, and Electrophysiological Characteristics of a New Model of Sustained Atrial Fibrillation

Carlos A. Morillo, MD; George J. Klein, MD, FRCPC, FACC; Douglas L. Jones, PhD, FACC; Colette M. Guiraudon, MD, FRCPC, FCAP

From the Departments of Medicine (C.A.M., G.J.K., D.L.J.), Physiology (D.L.J.), and Pathology (C.M.G.), University of Western Ontario, and the Heart and Circulation Group, The John P. Robarts Research Institute (C.A.M., G.J.K., D.L.J), London, Ontario, Canada.

Correspondence to Carlos A. Morillo, MD, Cardiovascular Physiology, Rm 3C-124, McGuire VA Medical Center, 1201 Broad Rock Blvd, Richmond, VA 23249.


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background Despite the clinical importance of atrial fibrillation (AF), the development of chronic nonvalvular AF models has been difficult. Animal models of sustained AF have been developed primarily in the short-term setting. Recently, models of chronic ventricular myopathy and fibrillation have been developed after several weeks of continuous rapid ventricular pacing. We hypothesized that chronic rapid atrial pacing would lead to atrial myopathy, yielding a reproducible model of sustained AF.

Methods and Results Twenty-two halothane-anesthetized mongrel dogs underwent insertion of a transvenous lead at the right atrial appendage that was continuously paced at 400 beats per minute for 6 weeks. Two-dimensional echocardiography was performed in 11 dogs to assess the effects of rapid atrial pacing on atrial size. Atrial vulnerability was defined as the ability to induce sustained repetitive atrial responses during programmed electrical stimulation and was assessed by extrastimulus and burst-pacing techniques. Effective refractory period (ERP) was measured at two endocardial sites in the right atrium. Sustained AF was defined as AF >=15 minutes. In animals with sustained AF, 10 quadripolar epicardial electrodes were surgically attached to the right and left atria. The local atrial fibrillatory cycle length (AFCL) was measured in a 20-second window, and the mean AFCL was measured at each site. Marked biatrial enlargement was documented; after 6 weeks of continuous rapid atrial pacing, the left atrium was 7.8±1 cm2 at baseline versus 11.3±1 cm2 after pacing, and the right atrium was 4.3±0.7 cm2 at baseline versus 7.2±1.3 cm2 after pacing. An increase in atrial area of at least 40% was necessary to induce sustained AF and was strongly correlated with the inducibility of AF (r=.87). Electron microscopy of atrial tissue demonstrated structural changes that were characterized by an increase in mitochondrial size and number and by disruption of the sarcoplasmic reticulum. After 6 weeks of continuous rapid atrial pacing, sustained AF was induced in 18 dogs (82%) and nonsustained AF was induced in 2 dogs (9%). AF occurred spontaneously in 4 dogs (18%). Right atrial ERP, measured at cycle lengths of 400 and 300 milliseconds at baseline, was significantly shortened after pacing, from 150±8 to 127±10 milliseconds and from 147±11 to 123±12 milliseconds, respectively (P<.001). This finding was highly predictive of inducibility of AF (90%). Increased atrial area (40%) and ERP shortening were highly predictive for the induction of sustained AF (88%). Local epicardial ERP correlated well with local AFCL (R2=.93). Mean AFCL was significantly shorter in the left atrium (81±8 milliseconds) compared with the right atrium 94±9 milliseconds (P<.05). An area in the posterior left atrium was consistently found to have a shorter AFCL (74±5 milliseconds). Cryoablation of this area was attempted in 11 dogs. In 9 dogs (82%; mean, 9.0±4.0; range, 5 to 14), AF was terminated and no longer induced after serial cryoablation.

Conclusions Sustained AF was readily inducible in most dogs (82%) after rapid atrial pacing. This model was consistently associated with biatrial myopathy and marked changes in atrial vulnerability. An area in the posterior left atrium was uniformly shown to have the shortest AFCL. The results of restoration of sinus rhythm and prevention of inducibility of AF after cryoablation of this area of the left atrium suggest that this area may be critical in the maintenance of AF in this model.


Key Words: fibrillation • electrophysiology


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Atrial fibrillation (AF) remains the most frequently encountered arrhythmia in the clinical setting.1 2 3 Despite this, the management of AF remains less than satisfactory. Most AF animal models have been developed in the short-term setting, and AF has been maintained in these models by pharmacological or electrical stimulation of the vagus nerve.4 5 6 7 Cox et al8 recently developed an AF model in anesthetized dogs after surgically inducing mitral regurgitation. AF was induced by programmed electrical stimulation in 19 of 22 (75%) dogs. The major limitation of these models is failure to sustain AF over prolonged periods.

Conversely, the study of ventricular arrhythmias, particularly ventricular fibrillation, has been strengthened by the development of reproducible animal models. Tachycardia-induced cardiomyopathy achieved by chronic rapid ventricular pacing has been reported recently.9 10 11 In this model, marked structural, functional, and electrophysiological changes were documented and are associated with ventricular fibrillation.10 We therefore hypothesized that chronic rapid atrial pacing would lead to atrial myopathy, thus yielding a reproducible model of sustained AF.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Study Animals
Twenty-two adult mongrel dogs weighing 16 to 30 kg each were used. Baseline 12-lead ECG, white blood cell count, and hemoglobin, serum creatinine, and electrolyte levels were measured to exclude unhealthy animals. The protocol was approved by the University Council on Animal Care of the University of Western Ontario and was completed in accordance with the Guidelines to the Care and Use of Experimental Animals of the Canadian Council on Animal Care.

Baseline Study
The dogs were tranquilized with an injection of acepromazine (0.3 to 0.4 mg/kg body wt IM) for transportation to the laboratory and then anesthetized with a mixture of 4% halothane, 2 L/min nitrous oxide, 1 L/min oxygen, and 2 L/min medical air administered by mask. The dogs were then intubated and ventilated at a rate of 10 to 12 breaths per minute and a tidal volume of 12 to 15 mL/kg with a Hospital 300 Anesthesia Ventilator (Hospital Medical Corporation). The halothane level was subsequently reduced to 0.5% to 1%. A circulating water blanket and controller were used to maintain body temperature at 37±1°C. Lactated Ringer's solution was infused throughout the procedure.

Two-dimensional echocardiography was performed in 11 dogs. Atrial size was assessed by calculating the atrial area by planimetry in the apical four-chamber view (Hewlett Packard 77025A U/S system, 2.5-mHz transducer). At least four repeated measurements were performed for both atria, and an average was calculated. Doppler ultrasound flow studies of the mitral and tricuspid valves were also performed.

Arterial pressure was continuously monitored by an indwelling catheter placed in the right femoral artery through a cut-down. Two 6F quadripolar catheters were inserted through direct cut-down of the left internal jugular vein and were fluoroscopically advanced to the right atrial (RA) appendage and lower RA, respectively. All data were continuously displayed on an Electronics for Medicine VR-16 switched-beam oscilloscope and were recorded periodically on photographic paper at 50 to 100 mm/s. The data were also recorded simultaneously on FM tape with a 16-channel Ampex PR 2230 recorder. The RA was stimulated at a pulse duration of 2 ms and twice diastolic threshold with a Grass S88 stimulator (Grass Medical Instruments). A custom-designed timer was used to trigger the stimulator.

Baroreceptor reflex sensitivity was assessed in all dogs by the method of Smyth et al.12 The dogs were given 10 to 40 µg/kg phenylephrine HCl (Neo-Synephrine, Winthrop Laboratories) until an increase of 30 to 40 mm Hg was achieved.13 The dose that achieved the targeted increase in blood pressure was repeated three times. Each RR interval was plotted as a function of the preceding systolic blood pressure, and beat-by-beat analysis was performed when the RR interval changed. A least-squares-fit linear regression was performed, and reflex control of the heart rate was expressed as the slope of the linear regression line. The three slopes obtained were averaged, and a mean baroreceptor slope was calculated for each dog.

Electrophysiological Study
P-wave duration was measured from the surface ECG at baseline and after pacing. The PA interval was measured from the onset of the P wave on the surface ECG to the onset of the atrial electrogram recorded at the lower RA.

The atrial effective refractory period (ERP) was measured at two endocardial sites, the RA appendage and the lower RA, by delivering a train of eight atrial paced beats S1 at two cycle lengths (400 and 300 ms), followed by an extrastimulus (S2) introduced at coupling intervals decremented by 10 ms to scan the entire atrial diastolic interval. Responses were monitored on a Tektronix 5513 storage oscilloscope. Atrial ERP was defined as the longest S1-S2 interval that failed to result in atrial depolarization.

Atrial vulnerability was defined as the ability to induce sustained atrial repetitive responses during programmed electrical stimulation. Inducibility of AF was determined by programmed electrical stimulation at basic cycle lengths of 400 and 300 ms with up to three extrastimuli (S4) delivered. The second extrastimulus (S3) was introduced with the S1-S2 interval fixed at 30 ms longer than the atrial ERP. The S2-S3 interval was set at 80% of the basic cycle length, introducing the extrastimulus with 10-ms scanning decrements. If double extrastimuli failed to induce arrhythmia, a third extrastimulus (S4) was introduced by use of the same protocol. If the latter protocol failed to induce AF, burst pacing at a cycle length of 100 ms for 20 to 30 seconds was tried. Nonsustained AF was defined as repetitive atrial responses lasting <5 minutes and spontaneously terminating. Sustained AF was defined as irregular repetitive atrial responses lasting >15 minutes.

After the programmed stimulation protocol was completed, all catheters were withdrawn and the right femoral artery was ligated. A unipolar screw-in Medtronic J pacing lead was inserted through the left jugular vein incision, and the tip of the lead was fluoroscopically placed and fixed in the RA appendage. The proximal end of the pacing lead was connected to a custom-modified Medtronic programmable pulse generator (5941,8322,8329) and subsequently implanted in a subcutaneous pocket in the neck. The pacemaker was set at 70 beats per minute (bpm) in the demand mode. After all the incisions were closed, the dogs were allowed to recover from anesthesia and were returned to the animal quarters.

Twenty-four hours were allowed for lead stabilization, and then the pacemaker was programmed to 400 bpm (150 ms) and maintained at this rate for 6 weeks. This invariably resulted in a mean ventricular rate of approximately 130 bpm. The surface ECG was checked at 2-week intervals to ensure constant pacing.

Restudy
Six weeks after the initial study, the pacemaker was programmed to the lowest rate attainable and the dogs were studied by use of the same procedure described for the baseline study. Two-dimensional echocardiography was assessed in the 11 dogs with baseline echo. P-wave duration and PA interval were measured before electrophysiological study. Baroreceptor reflex sensitivity was evaluated in all dogs by use of the protocol previously described. Atrial ERP and AF vulnerability were determined by insertion of a catheter through the right jugular vein. Once sustained AF was induced, the chest was opened by means of a median sternotomy and the heart was exposed and suspended in a pericardial sling. Sinus rhythm was restored by electric cardioversion delivered with epicardial paddles when necessary. Ten quadripolar plaque electrodes (interelectrode distance, 10 mm) were surgically attached to the RA and left atrial (LA) walls (Fig 1Down). Bipolar epicardial electrograms were continuously recorded on magnetic tape and stored on diskette for off-line signal processing by a computerized mapping system (CMS 1000, Biomedical Instrumentation). Local epicardial AF cycle length (AFCL) was calculated by measuring the interval between the steepest negative deflection of each activation point in a 20-second window and averaged to obtain the mean AFCL. In 8 dogs, local epicardial ERP was measured at each site and correlated with the local AFCL. In 11 dogs, cryoablation at -30° to -45°C with a 10-mm probe (Frigitronics model CCS 100) for 120 seconds was serially applied to the area with shortest AFCL.



View larger version (19K):
[in this window]
[in a new window]
 
Figure 1. Diagram showing a posterior view, indicating the location and distribution of the atrial epicardial electrodes. Four quadripolar plaque electrodes (diameter, 1.5 mm; interelectrode distance, 10 mm) were sutured to the right atrial (RA) and left atrial (LA) walls from the posterior wall toward the atrial appendages (electrodes 1 through 4). Two quadripolar plaque electrodes were also sutured to the right and left Bachman bundles. ICV indicates inferior caval vein; PV, pulmonary veins; and SCV, superior caval vein.

After the restudy was completed, the heart was excised and examined for size and gross abnormalities. Both atria were removed and sent to the pathology department for light and electron microscopic studies.

Statistical Analysis
Values are expressed as mean±SD. Paired Student's t test was used to compare mean values between baseline and restudy. Linear regression analysis was used to evaluate the relation between epicardial ERP and local mean AFCL. Baroreceptor reflex sensitivity was assessed by a least-squares-fit linear regression, and reflex control of heart rate was expressed as the slope of the linear regression line. Only slopes with a correlation coefficient of >=.80 were accepted for analysis. The slopes were averaged, and a mean baroreceptor slope was calculated for each dog by one-way ANOVA. The null hypothesis was rejected at the P=.05 level.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Two-dimensional Echocardiography
After 6 weeks of continuous rapid atrial pacing, biatrial enlargement was documented in the 11 dogs assessed by echocardiography (Fig 2Down). The areas of both atria were markedly increased: the LA increased from 7.8±1 to 11.3±1 cm2 (45%) and the RA from 4.3±0.7 to 7.2±1.3 cm2 (67%, P<.001). Mild tricuspid regurgitation was documented after pacing in 3 of 11 dogs (25%). No evidence of significant mitral or tricuspid valve dysfunction was observed at either baseline or restudy.



View larger version (117K):
[in this window]
[in a new window]
 
Figure 2. Two-dimensional echocardiogram of a dog heart, showing an apical view of the left (A and B) and right (C and D) atrial chambers at baseline (A and C) and after 6 weeks of rapid atrial pacing (B and D). A and C, Left atrial (La, 6.85 cm2) and right atrial (Ra, 3.99 cm2) areas, respectively, at baseline. Marked biatrial enlargement is demonstrated after 6 weeks of atrial pacing: left atrial area is 11.7 cm2 (B) and right atrial area is 9.50 cm2 (D). Lv indicates left ventricle; Rv, right ventricle.

Baroreceptor Reflex Sensitivity
After 6 weeks of continuous rapid atrial pacing, no changes in the baroreceptor reflex sensitivity slopes were observed (26.39±14.87 versus 28.08±12.38 ms/mm Hg at baseline, P=NS).

Structural Changes
Light Microscopy
Focal and early hypertrophy were observed in both atria. Also, in most cases, large mural thrombi were also found in either the LA or RA. No evidence of increased connective tissue content was documented.

Electron Microscopy
Severe changes in the architecture of both LA and RA were documented by electron microscopy after 6 weeks of rapid atrial pacing. These changes were characterized by a marked increase in the number and size of the mitochondria and by disruption of the sarcoplasmic reticulum (Fig 3Down). Enlarged nuclei and dilatation of the rough endoplasmic reticulum were also observed. These changes are consistent with hypertrophy and perturbation of the cellular metabolic activity. No changes were observed in ventricular samples assessed randomly in eight dogs.



View larger version (151K):
[in this window]
[in a new window]
 
Figure 3. A, Low-power electron microscopy (x900) of right atrial tissue from the same dog as in Fig 2Up, showing enlarged and disarrayed fibers and giant mitochondria. Moderate dilation of the rough endoplasmic reticulum is also shown. B, High-power electron microscopy (x2100) of the same sample, showing giant mitochondria with disintegrated crystae and an anarchic pattern. These findings are consistent with hypertrophy and perturbation of metabolic activity.

Electrophysiological Findings
P-wave duration and PA interval were assessed at baseline and after 6 weeks of chronic rapid atrial pacing. Significant increases in P-wave duration and PA interval were observed after pacing (55.5±7.5 versus 88.8±8.5 ms and 36.8±10.6 versus 55.5±9.8 ms, respectively, P<.05). A significant reduction in endocardial RA ERP was documented after chronic rapid atrial pacing at cycle length drives of 400 and 300 ms (150±8 to 127±10 ms and 147±11 to 123±12 ms, respectively, P<.001). Sustained AF was not induced by programmed electrical stimulation at baseline study in any dog. In contrast, sustained AF was readily inducible by programmed electrical stimulation in 11 of 22 dogs (Fig 4Down). Of 11 total dogs, AF was induced by a single extrastimulus in 6 dogs, by two extrastimuli in 3, and by three extrastimuli in 2. Burst pacing was necessary to induce AF in another 7 dogs. AF was induced at least twice with the same extrastimulation protocol in 15 of 18 (83%) dogs. Nonsustained atrial flutter was induced in 2 of the remaining 4 dogs. The mean ventricular response during sustained AF was 595±85 ms. Nonsustained AF was induced in 2 dogs (9%). After programming the pacemaker to the lowest heart-rate setting, AF occurred spontaneously in 4 dogs (18%). These episodes of spontaneous AF were not initiated or preceded by premature atrial contractions. Overall, sustained AF was induced at restudy in 18 of 22 (82%) dogs at a mean duration of 45±7 minutes.



View larger version (17K):
[in this window]
[in a new window]
 
Figure 4. ECGs showing induction of atrial fibrillation (AF) after 6 weeks of rapid atrial pacing by programmed electrical stimulation. A single extrastimulus (S2) delivered at a coupling interval of 130 ms induces sustained AF. ECG leads I and II are shown. Ae indicates right atrial electrogram; Ao, aortic pressure. S1S1 is the basic pacing cycle length.

An increase in atrial area of at least 40% was strongly correlated with the inducibility of sustained AF (r=.87). A 15% reduction in ERP was associated with increased atrial vulnerability. When these variables were combined, the positive predictive value for the induction of sustained AF was 88%.

Mean AFCL was significantly shorter in the LA (81±8 ms) compared with the RA (94±9 ms, P<.05). Mean AFCL was correlated with the local epicardial refractory period in 8 dogs, and a strong correlation (R2=.93) between these two measurements was achieved (Fig 5Down). Epicardial AFCL showed a significant variance (SD2) between sites (LA, 36.5 ms2; RA, 30.5 ms2), suggesting increased dispersion in refractoriness. Detailed analysis of the mean AFCL showed that an area localized to the posterior LA (74±6 ms) had a consistently faster AFCL than the rest of the epicardial sites (Fig 6Down). This area was always localized to the inferoposterior LA adjacent to the left inferior pulmonary vein. Cryoablation of this area was attempted in 11 dogs (Fig 7Down), with a mean of 9 applications.5 6 7 8 9 10 11 12 13 14 The area ablated was between {approx}5 and 8 cm2. Before AF was terminated, AFCL was significantly prolonged in both atria (LA, 81±8 to 132±5 ms; RA, 94±9 to 136±4 ms, P<.0001). AF was terminated in 9 of 11 (82%) dogs (Fig 8Down). Sustained AF was no longer inducible by either programmed electrical stimulation or burst pacing; instead, nonsustained atrial flutter was induced in 7 of 9 (77%) dogs.



View larger version (11K):
[in this window]
[in a new window]
 
Figure 5. Graph showing relation between the mean atrial fibrillation cycle length (AFCL) and atrial effective refractory period (ERP) determined by the extrastimulus technique at a basic cycle length of 400 ms at 10 epicardial sites in eight dogs with sustained AF. A high correlation coefficient (R2=.93) was achieved between AFCL and ERP.



View larger version (41K):
[in this window]
[in a new window]
 
Figure 6. Top, distribution of the epicardial electrodes on both atria. Shortest atrial fibrillation cycle length is localized to the inferoposterior left atrium (LA1=90 ms). Bottom, electrograms showing sustained atrial fibrillation induced by programmed electrical stimulation. Surface ECG lead II, eight bipolar epicardial electrograms, and the mean atrial fibrillation cycle length are shown. Abbreviations are the same as in Fig 1Up.



View larger version (20K):
[in this window]
[in a new window]
 
Figure 7. Diagram showing cryoablation directed to the area with the shortest atrial fibrillation cycle length that was consistently localized to the left inferoposterior atrium (arrowheads). Abbreviations and further explanation are as in Fig 1Up.



View larger version (35K):
[in this window]
[in a new window]
 
Figure 8. Diagram (top) and surface ECG lead II and eight bipolar epicardial electrograms (A, B, and C) are shown. Top, Distribution of the epicardial electrodes; arrowheads indicate the area ablated. A, Sustained AF before the application of cryoablation of the area with the shortest atrial fibrillation cycle length localized to the left inferoposterior atrium (LA1, LA2). B, One minute after initiation of cryoablation application, indicated by a decrease in the amplitude of ECGs at the site of ablation. **Marked prolongation of atrial cycle length resembling atrial flutter was achieved. C, Termination of atrial fibrillation and conversion to sinus rhythm were preceded by atrial flutter (continuous strips). Abbreviations are as in Fig 1Up.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
The present study describes the characteristics of a new canine model of sustained AF. This model may be the experimental counterpart of clinically observed cardiomyopathy induced by tachycardia.14 15 16 Our model is highly reproducible, and sustained AF is readily inducible and can be maintained for prolonged periods of time.

Structural Changes
The marked changes in atrial architecture that were documented by electron microscopy, such as fiber disarray and early hypertrophy, may contribute to the maintenance of AF in this model. Disorganization of atrial fiber orientation may slow the rate of conduction, facilitating reentry.17 Similarly, alterations observed at the cellular level, such as the increase in mitochondrial size and disruption of the sarcoplasmic reticulum, may create ionic alterations that increase atrial vulnerability, triggering AF.

A marked increase in atrial size was documented by two-dimensional echocardiography. A 40% increase in atrial area was strongly correlated with the inducibility of sustained AF. This finding may contribute to the maintenance of AF in this model. This finding provides further support for the critical atrial mass hypothesis.18

A high incidence of mural thrombi in both atria was observed by light microscopy. However, two-dimensional echocardiography did not show any evidence of mural thrombi, and no clinical findings suggesting systemic embolization were documented. This model may further expand our understanding of the development of systemic emboli in the presence of chronic nonvalvular AF.

Baroreceptor Reflex Sensitivity
Depressed baroreceptor reflex sensitivity has been reported in the paced model of induced heart failure.19 Interestingly, no changes in baroreceptor function were noted after 6 weeks of continuous rapid atrial pacing. It is possible that the development of baroreceptor alterations in the paced induced heart failure model may be mediated by the presence of heart failure and not by the tachycardia per se. Finally, increased atrial vulnerability in our AF model cannot be attributed to alterations in autonomic balance, as evidenced by a preserved baroreceptor reflex sensitivity after pacing.

Electrophysiological Changes
Prolonged P-wave duration and PA interval were noted after pacing. A significant shortening of the RA ERP was also documented at restudy. A minimal reduction of 15% in ERP associated with an increase of at least 40% in atrial area was highly predictive of sustained AF. Similarly, local epicardial ERP measured at five sites in each atrium showed a marked dispersion of refractoriness. Local epicardial ERP was strongly correlated with local AFCL, a measure previously used in experimental20 21 22 and human studies23 as an index of local refractoriness. We found a significantly shorter AFCL in the LA compared with the RA. Further analysis of the mean AFCL demonstrated that an area localized to the posterior LA was consistently faster than the rest of the epicardial sites analyzed (Fig 6Up). The significant difference between the AFCL of the LA and RA may be explained by a shorter refractory period in the LA, modulated in part by differences in autonomic innervation.24 However, the exact mechanism leading to this difference remains unclear. The use of the AFCL as an index of refractoriness is based on the concept that, during fibrillation, a wandering wavelet will reexcite the cells as soon as they recover their excitability.20 21 22 23 Cryoablation of this area significantly prolonged AFCL in both atria and successfully restored sinus rhythm in most dogs (82%), rendering sustained AF noninducible. The ablated area may have been large enough to prevent reentry of multiple wavelets. These findings suggest that the ability to maintain AF in this model may be related to an area localized in the posterior LA that can sustain rapid atrial rates. It is possible to speculate that the increased susceptibility to AF in this model was triggered by alterations in the wavelength mediated by a shortened refractoriness and conduction depression. Although we did not determine the wavelength in this set of experiments, we did note a dispersion of refractoriness of 30.5 ms2 in the RA and 36.5 ms2 in the LA and increased right intra-atrial conduction delay, suggested by the increase in PA interval. The role of triggered activity as a potential mechanism in the generation of AF in this model cannot be entirely ruled out. Alterations in the microarchitecture and anisotropic properties may cause inhomogeneous and discontinuous propagation of the impulse.25 26 27 Depression of conduction in our model may be expected and could be related to the marked ultrastructural changes documented by electron microscopy. Altogether, these findings may be responsible for the increased atrial vulnerability noted in this model.

Previous Models
Previous AF models have been developed in dogs with structurally normal hearts. In these models, AF was generally sustained by electric or pharmacological stimulation of the parasympathetic nervous system.4 5 6 7 Allessie et al28 recently reported the induction of sustained AF by periodic burst pacing of the LA in five chronically instrumented dogs. These dogs were restudied 3 days after implanting a series of epicardial electrodes. Continuous atrial pacing was not performed in this model, and no evidence of structural changes in the atria was reported. These authors reported a significantly shorter AFCL in the LA, comparable to that reported in the present study. The same group recently developed a model of chronic AF by repeatedly inducing AF in chronically instrumented goats.29 In this model, AF was maintained by an external fibrillation pacemaker. Interestingly, the development of chronic AF was associated with a significant shortening of the atrial ERP and shortening of the AFCL. These findings are similar to those in the present study and provide further support for our model. Similarly, a model of acute AF achieved by rapid atrial pacing recently has been used to evaluate different atrial defibrillation waveforms.30 31 Cox et al8 recently developed an AF model in anesthetized dogs subjected to surgically inducing mitral regurgitation. AF was induced by programmed electrical stimulation in 19 of 22 (75%) dogs 3 months after the surgical procedure. We are aware of only one other "chronic" AF model, which used continuous bipolar 60-Hz AC atrial stimulation for the development of AF.32 In this model, in 4 of 6 dogs, AF persisted after the stimulation protocol was terminated. LA enlargement documented by two-dimensional echocardiography and comparable to that observed in our study was also reported. Although this model was reported in abstract form several years ago, no detailed data or a follow-up on this model is presently available. The model of AF described herein is unique, in that AF was associated with marked biatrial myopathy and increased atrial vulnerability in dogs without valvular disease.

Study Limitations
Insight into the mechanism leading to sustained AF in this model is limited by the lack of extensive atrial mapping and interelectrode conduction-time data. Nonetheless, we describe a reproducible new model of sustained AF and the functional, structural, and electrophysiological characteristics of this model.

Clinical Implications
The present study demonstrated the feasibility of developing a reproducible model of sustained AF without valvular disease. AF without overt underlying disease has been increasingly recognized in humans, and the possibility of expanding our understanding of the mechanisms leading to AF in this setting may be enhanced by the present model. Also, new therapeutic modalities may be facilitated by the use of the present novel model.


*    Acknowledgments
 
This work was supported by the Heart and Stroke Foundation of Canada. Dr C.A. Morillo is the recipient of a research fellowship award from the Heart and Stroke Foundation of Canada, Ottawa. Dr G.J. Klein is the recipient of a distinguished professorship of the Heart and Stroke Foundation of Ontario, Toronto, Canada. The authors thank G.K. Wood and R. Kaleda for excellent technical assistance.

Received June 1, 1994; revision received August 24, 1994; accepted September 5, 1994.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Kannel WB, Wolf PA. Epidemiology of atrial fibrillation. In: Falk RH, Podrid PJ, eds. Atrial Fibrillation: Mechanisms and Management. New York, NY: Raven Press; 1992:81-92.

2. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of atrial fibrillation. N Engl J Med. 1982;306: 1018-1022.

3. Onundarson PT, Thorgeirsson G, Jonmundsson E, Sigfusson N, Hardarson T. Chronic atrial fibrillation: epidemiologic features and 14 year follow-up: a case control study. Eur Heart J. 1987;8:521-527. [Abstract/Free Full Text]

4. Hoff HE, Geddes LA. Cholinergic factor in atrial fibrillation. J Appl Physiol. 1955;8:177-192. [Free Full Text]

5. Scher D. Studies on auricular tachycardia caused by aconitine administration. Proc Soc Exp Biol Med N Y. 1947;64:223-239.

6. Rosenblueth A, Garcia Ramos J. Studies on flutter and fibrillation: the influence of artificial obstacles on experimental auricular flutter. Am Heart J. 1947;33:677-684.

7. Moe GK, Abildskov JA. Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. Am Heart J. 1959;58: 59-70.

8. Cox JL, Canavan TE, Schuessler RB, Cain ME, Lindsay BD, Stone C, Smith PK, Corr PB, Boineau JP. The surgical treatment of atrial fibrillation, II: intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial fibrillation. J Thorac Cardiovasc Surg. 1991;101:406-426. [Abstract]

9. Armstrong PW, Stopps TP, Ford SE, DeBold AJ. Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure. Circulation. 1986;74:1075-1084. [Abstract/Free Full Text]

10. Wilson JR, Douglas P, Hickey WF, Lanoce V, Ferraro N, Muhammad A, Reichek N. Experimental congestive heart failure produced by rapid ventricular pacing in the dog: cardiac effects. Circulation. 1987;75:857-867. [Abstract/Free Full Text]

11. Li HG, Jones DL, Yee R, Klein GJ. Electrophysiologic substrate associated with pacing-induced heart failure in dogs: potential value of programmed stimulation in predicting sudden death. J Am Coll Cardiol. 1992;19:444-449. [Abstract]

12. Smyth HS, Sleight P, Pickering GW. Reflex regulation of arterial pressure during sleep in man: a quantitative method of assessing baroreceptor sensitivity. Circ Res. 1969;24:109-121. [Abstract/Free Full Text]

13. Billman GE, Schwartz PJ, Stone LH. Baroreceptor reflex control of heart rate: a predictor of sudden cardiac death. Circulation. 1982;66:874-880. [Free Full Text]

14. Packer DL, Bardy GH, Worley SJ, Smith MS, Cobb FR, Coleman RE, Gallagher JJ, German LD. Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction. Am J Cardiol. 1986;57:563-570. [Medline] [Order article via Infotrieve]

15. Giogi LV, Hartzler GO, Harnaker WR. Incessant focal atrial tachycardia: a surgically remediable cause of cardiomyopathy. J Thorac Cardiovasc Surg. 1984;87:466-473. [Abstract]

16. Damiano RJ Jr, Tripp HF, Asano T, Small KW, Jones RH, Lowe JE. Left ventricular dysfunction and dilatation resulting from chronic supraventricular tachycardia. J Thorac Cardiovasc Surg. 1987;94:135-143. [Abstract]

17. Weber KT, Pick R, Silver MA, Moe GW, Janicki JS, Zucker IH, Armstrong PW. Fibrillar collagen and remodeling of dilated canine left ventricle. Circulation. 1990;82:1387-1401. [Abstract/Free Full Text]

18. Garrey WE. The nature of fibrillary contraction of the heart: its relation to tissue mass and form. Am J Physiol. 1914;33:397-414.

19. Chen JS, Wang W, Bartholet T, Zucker IH. Analysis of baroreflex control of heart rate in conscious dogs with pacing-induced heart failure. Circulation. 1991;83:260-267. [Abstract/Free Full Text]

20. Lammers WJEP, Allessie MA, Rensma PL, Schalij MJ. The use of fibrillation cycle length to determine spatial refractoriness in electrophysiological properties and to characterize the underlying mechanism of fibrillation. New Trends Arrhythmias. 1986;2:109-112.

21. Opthof T, Ramdat Misier AR, Coronel R, Vermeulen JT, Verberne HJ, Frank RGJ, Moulijn AC, van Capelle FJL, Janse MJ. Dispersion of refractoriness in canine ventricular myocardium: effects of sympathetic stimulation. Circ Res. 1991;68:1204-1215. [Abstract/Free Full Text]

22. Kim KB, Rodefeld MD, Schuessler RB, Boineau JP, Cox JL. Minimum atrial fibrillation interval estimates refractory period in the isolated canine bi-atrial preparation. PACE Pacing Clin Electrophysiol. 1994;17:839. Abstract.

23. Ramdat Misier AR, Opthof T, van Hemel NM, Defauw JJAM, de Bakker JMT, Janse MJ, van Capelle FJL. Increased dispersion of `refractoriness' in patients with idiopathic atrial fibrillation. J Am Coll Cardiol. 1992;19:1531-1535. [Abstract]

24. Rensma PL, Allessie MA, Lammers WJEP, Bonke FIM, Schalij MJ. Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs. Circ Res. 1988;62:395-410. [Abstract/Free Full Text]

25. Spach MS, Kootsey JM, Sloan JD. Active modulation of electrical coupling between cardiac cells of the dog: a mechanism for transient and steady state variations in conduction velocity. Circ Res. 1982;51:347-362. [Abstract/Free Full Text]

26. Spach MS, Dolber PC. Relating extracellular potentials and their derivative to anisotropic propagation at a microscopic level in human cardiac muscle. Circ Res. 1986;58:356-371. [Abstract/Free Full Text]

27. Spach MS, Miller WT, Geselowitz DB, Barr RC, Kootsey JM, Johnson EA. The discontinuous nature of propagation in normal canine cardiac muscle. Circ Res. 1981;48:39-54. [Free Full Text]

28. Allessie M, Kirchhof C, Scheffer GJ, Chorro F, Brugada J. Regional control of atrial fibrillation by rapid pacing in conscious dogs. Circulation. 1991;84:1689-1697. [Abstract/Free Full Text]

29. Wijffels M, Kirchhof C, Fredericks J, Boersma L, Allessie M. Atrial fibrillation begets atrial fibrillation. Circulation. 1993;88(suppl I):I-18. Abstract.

30. Powell AC, Garan H, McGovern BA, Fallon JT, Krishnan SC, Ruskin JN. Low energy conversion of atrial fibrillation in the sheep. J Am Coll Cardiol. 1992;20:707-711. [Abstract]

31. Cooper RAS, Alferness CA, Smith WM, Ideker RE. Internal cardioversion of atrial fibrillation in sheep. Circulation. 1993;87: 1673-1683.

32. Salmon DR, McPherson DD, Augustine DE, Holida MD, White CW. A canine model of chronic atrial fibrillation: echocardiographic and electrocardiographic validation. Circulation. 1985;72(suppl III):III-250. Abstract.




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
S.-M. Chaldoupi, P. Loh, R. N.W. Hauer, J. M.T. de Bakker, and H. V.M. van Rijen
The role of connexin40 in atrial fibrillation
Cardiovasc Res, July 7, 2009; (2009) cvp203v2.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. K. Stiles, B. John, C. X. Wong, P. Kuklik, A. G. Brooks, D. H. Lau, H. Dimitri, K. C. Roberts-Thomson, L. Wilson, P. De Sciscio, et al.
Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate characterizing the "second factor".
J. Am. Coll. Cardiol., April 7, 2009; 53(14): 1182 - 1191.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. S. Oakes, T. J. Badger, E. G. Kholmovski, N. Akoum, N. S. Burgon, E. N. Fish, J. J.E. Blauer, S. N. Rao, E. V.R. DiBella, N. M. Segerson, et al.
Detection and Quantification of Left Atrial Structural Remodeling With Delayed-Enhancement Magnetic Resonance Imaging in Patients With Atrial Fibrillation
Circulation, April 7, 2009; 119(13): 1758 - 1767.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
R. F. Berntsen, A. Cheng, H. Calkins, and R. D. Berger
Evaluation of spatiotemporal organization of persistent atrial fibrillation with time- and frequency-domain measures in humans
Europace, March 1, 2009; 11(3): 316 - 323.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Michael, L. Xiao, X.-Y. Qi, D. Dobrev, and S. Nattel
Remodelling of cardiac repolarization: how homeostatic responses can lead to arrhythmogenesis
Cardiovasc Res, February 15, 2009; 81(3): 491 - 499.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Shiroshita-Takeshita, H. Mitamura, S. Ogawa, and S. Nattel
Rate-dependence of atrial tachycardia effects on atrial refractoriness and atrial fibrillation maintenance
Cardiovasc Res, January 1, 2009; 81(1): 90 - 97.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
H. L. Estner, G. Hessling, G. Ndrepepa, J. Wu, T. Reents, S. Fichtner, C. Schmitt, C. V. Bary, C. Kolb, M. Karch, et al.
Electrogram-guided substrate ablation with or without pulmonary vein isolation in patients with persistent atrial fibrillation
Europace, November 1, 2008; 10(11): 1281 - 1287.
[Abstract] [Full Text] [PDF]


Home page
Circ Arrhythmia ElectrophysiolHome page
F. Gaita, D. Caponi, M. Scaglione, A. Montefusco, A. Corleto, F. Di Monte, D. Coin, P. Di Donna, and C. Giustetto
Long-Term Clinical Results of 2 Different Ablation Strategies in Patients With Paroxysmal and Persistent Atrial Fibrillation
Circ Arrhythmia Electrophysiol, October 1, 2008; 1(4): 269 - 275.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Remes, T. J. van Brakel, G. Bolotin, C. Garber, M. M. de Jong, F. H. van der Veen, and J. G. Maessen
Persistent atrial fibrillation in a goat model of chronic left atrial overload.
J. Thorac. Cardiovasc. Surg., October 1, 2008; 136(4): 1005 - 1011.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Etzion, M. Mor, A. Shalev, S. Dror, O. Etzion, A. Dagan, O. Beharier, A. Moran, and A. Katz
New insights into the atrial electrophysiology of rodents using a novel modality: the miniature-bipolar hook electrode
Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1460 - H1469.
[Abstract] [Full Text] [PDF]


Home page
Circ Arrhythmia ElectrophysiolHome page
Z. Lu, B. J. Scherlag, J. Lin, G. Niu, K.-M. Fung, L. Zhao, M. Ghias, W. M. Jackman, R. Lazzara, H. Jiang, et al.
Atrial Fibrillation Begets Atrial Fibrillation: Autonomic Mechanism for Atrial Electrical Remodeling Induced by Short-Term Rapid Atrial Pacing
Circ Arrhythmia Electrophysiol, August 1, 2008; 1(3): 184 - 192.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Rostock, D. Steven, B. Lutomsky, H. Servatius, I. Drewitz, H. Klemm, K. Mullerleile, R. Ventura, T. Meinertz, and S. Willems
Atrial fibrillation begets atrial fibrillation in the pulmonary veins on the impact of atrial fibrillation on the electrophysiological properties of the pulmonary veins in humans.
J. Am. Coll. Cardiol., June 3, 2008; 51(22): 2153 - 2160.
[Abstract] [Full Text] [PDF]


Home page
Ther Adv Cardiovasc DisHome page
J. L. Serra and M. Bendersky
Review: Atrial fibrillation and renin-angiotensin system
Therapeutic Advances in Cardiovascular Disease, June 1, 2008; 2(3): 215 - 223.
[Abstract] [PDF]


Home page
Circ Arrhythmia ElectrophysiolHome page
T. W. Lim, C. H. Koay, R. McCall, V. A. See, D. L. Ross, and S. P. Thomas
Atrial Arrhythmias After Single-Ring Isolation of the Posterior Left Atrium and Pulmonary Veins for Atrial Fibrillation: Mechanisms and Management
Circ Arrhythmia Electrophysiol, June 1, 2008; 1(2): 120 - 126.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
A. Bukowska, L. Schild, G. Keilhoff, D. Hirte, M. Neumann, A. Gardemann, K. H. Neumann, F.-W. Rohl, C. Huth, A. Goette, et al.
Mitochondrial Dysfunction and Redox Signaling in Atrial Tachyarrhythmia
Experimental Biology and Medicine, May 1, 2008; 233(5): 558 - 574.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Laurent, G. Moe, X. Hu, H. Leong-Poi, K. A. Connelly, P. P.-S. So, A. Ramadeen, L. Doumanovskaia, A. Konig, J. Trogadis, et al.
Experimental studies of atrial fibrillation: a comparison of two pacing models
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1206 - H1215.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. C. Roberts-Thomson, I. H. Stevenson, P. M. Kistler, H. M. Haqqani, J. C. Goldblatt, P. Sanders, and J. M. Kalman
Anatomically Determined Functional Conduction Delay in the Posterior Left Atrium: Relationship to Structural Heart Disease
J. Am. Coll. Cardiol., February 26, 2008; 51(8): 856 - 862.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. Casaclang-Verzosa, B. J. Gersh, and T. S.M. Tsang
Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation.
J. Am. Coll. Cardiol., January 1, 2008; 51(1): 1 - 11.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. P. Regan, L. Kiss, G. L. Stump, C. J. McIntyre, D. C. Beshore, N. J. Liverton, C. J. Dinsmore, and J. J. Lynch Jr.
Atrial Antifibrillatory Effects of Structurally Distinct IKur Blockers 3-[(Dimethylamino)methyl]-6-methoxy-2-methyl-4-phenylisoquinolin-1(2H)-one and 2-Phenyl-1,1-dipyridin-3-yl-2-pyrrolidin-1-yl-ethanol in Dogs with Underlying Heart Failure
J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 322 - 330.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
E. Pruvot, F. Jousset, P. Ruchat, J.-M. Vesin, Y. Prudat, T. Zerm, and M. Fromer
Propagation velocity kinetics and repolarization alternans in a free-behaving sheep model of pacing-induced atrial fibrillation
Europace, November 1, 2007; 9(suppl_6): vi83 - vi88.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. D. O'Neill, P. Jais, M. Hocini, F. Sacher, G. J. Klein, J. Clementy, and M. Haissaguerre
Catheter Ablation for Atrial Fibrillation
Circulation, September 25, 2007; 116(13): 1515 - 1523.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Ozgen, W. Dun, E. A. Sosunov, E. P. Anyukhovsky, M. Hirose, H. S. Duffy, P. A. Boyden, and M. R. Rosen
Early electrical remodeling in rabbit pulmonary vein results from trafficking of intracellular SK2 channels to membrane sites
Cardiovasc Res, September 1, 2007; 75(4): 758 - 769.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. Sanders, M. Hocini, P. Jais, F. Sacher, L.-F. Hsu, Y. Takahashi, M. Rotter, T. Rostock, C. J. Nalliah, J. Clementy, et al.
Complete isolation of the pulmonary veins and posterior left atrium in chronic atrial fibrillation. Long-term clinical outcome
Eur. Heart J., August 1, 2007; 28(15): 1862 - 1871.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
K. A. Hafid, H. C. Xin, W. Xi, Z. Q. Yan, and Y. Bo
Difference between electrical remodelling after pulmonary veins and right atrium appendage pacing
Europace, July 13, 2007; (2007) eum108v1.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
H. Calkins, J. Brugada, D. L. Packer, R. Cappato, S.-A. Chen, H. J.G. Crijns, R. J. Damiano Jr, D. W. Davies, D. E. Haines, M. Haissaguerre, et al.
HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and Approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society.
Europace, June 1, 2007; 9(6): 335 - 379.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. Cingoz, G. Yanulis, E. Ching, K. Fukamachi, and D. W. Wallick
Use of Conventional Dual Chamber Pacemakers With Custom Lead Adapters to Induce Atrial Fibrillation or Heart Failure in Dogs
Ann. Thorac. Surg., May 1, 2007; 83(5): 1858 - 1862.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. Nattel, A. Maguy, S. Le Bouter, and Y.-H. Yeh
Arrhythmogenic Ion-Channel Remodeling in the Heart: Heart Failure, Myocardial Infarction, and Atrial Fibrillation
Physiol Rev, April 1, 2007; 87(2): 425 - 456.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. C.M. Choisy, L. A. Arberry, J. C. Hancox, and A. F. James
Increased Susceptibility to Atrial Tachyarrhythmia in Spontaneously Hypertensive Rat Hearts
Hypertension, March 1, 2007; 49(3): 498 - 505.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
J.-q. Zhong, W. Zhang, H. Gao, Y. Li, M. Zhong, D. Li, C. Zhang, and Y. Zhang
Changes in connexin 43, metalloproteinase and tissue inhibitor of metalloproteinase during tachycardia-induced cardiomyopathy in dogs
Eur J Heart Fail, January 1, 2007; 9(1): 23 - 29.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. H. Everett IV, E. E. Wilson, S. Verheule, J. M. Guerra, S. Foreman, and J. E. Olgin
Structural atrial remodeling alters the substrate and spatiotemporal organization of atrial fibrillation: a comparison in canine models of structural and electrical atrial remodeling
Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2911 - H2923.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 651 - 745.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246.
[Full Text] [PDF]


Home page
CirculationHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation, August 15, 2006; 114(7): e257 - e354.
[Full Text] [PDF]


Home page
EuropaceHome page
I. Deisenhofer, H. Estner, B. Zrenner, J. Schreieck, S. Weyerbrock, G. Hessling, K. Scharf, M. R. Karch, and C. Schmitt
Left atrial tachycardia after circumferential pulmonary vein ablation for atrial fibrillation: incidence, electrophysiological characteristics, and results of radiofrequency ablation.
Europace, August 1, 2006; 8(8): 573 - 582.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T.-J. Cha, J. R. Ehrlich, D. Chartier, X.-Y. Qi, L. Xiao, and S. Nattel
Kir3-Based Inward Rectifier Potassium Current: Potential Role in Atrial Tachycardia Remodeling Effects on Atrial Repolarization and Arrhythmias
Circulation, April 11, 2006; 113(14): 1730 - 1737.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Mansour
Highest Dominant Frequencies in Atrial Fibrillation: A New Target for Ablation?
J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1408 - 1409.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Shiroshita-Takeshita, B. J.J.M. Brundel, J. Lavoie, and S. Nattel
Prednisone prevents atrial fibrillation promotion by atrial tachycardia remodeling in dogs
Cardiovasc Res, March 1, 2006; 69(4): 865 - 875.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Haissaguerre, M. Hocini, P. Sanders, Y. Takahashi, M. Rotter, F. Sacher, T. Rostock, L.-F. Hsu, A. Jonsson, M. D. O'Neill, et al.
Localized Sources Maintaining Atrial Fibrillation Organized by Prior Ablation
Circulation, February 7, 2006; 113(5): 616 - 625.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Reant, S. Lafitte, P. Jais, K. Serri, R. Weerasooriya, M. Hocini, X. Pillois, J. Clementy, M. Haissaguerre, and R. Roudaut
Reverse Remodeling of the Left Cardiac Chambers After Catheter Ablation After 1 Year in a Series of Patients With Isolated Atrial Fibrillation
Circulation, November 8, 2005; 112(19): 2896 - 2903.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Zhang, H. Yamada, S. Bibevski, S. Zhuang, K. A. Mowrey, D. W. Wallick, S. Oh, and T. N. Mazgalev
Chronic Atrioventricular Nodal Vagal Stimulation: First Evidence for Long-Term Ventricular Rate Control in Canine Atrial Fibrillation Model
Circulation, November 8, 2005; 112(19): 2904 - 2911.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
G. V. Naccarelli
Antiadrenergic Therapy in the Control of Atrial Fibrillation
Journal of Cardiovascular Pharmacology and Therapeutics, October 1, 2005; 10(4_suppl): S33 - S43.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
D. J. Milan and C. A. MacRae
Animal models for arrhythmias
Cardiovasc Res, August 15, 2005; 67(3): 426 - 437.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Sanders, O. Berenfeld, M. Hocini, P. Jais, R. Vaidyanathan, L.-F. Hsu, S. Garrigue, Y. Takahashi, M. Rotter, F. Sacher, et al.
Spectral Analysis Identifies Sites of High-Frequency Activity Maintaining Atrial Fibrillation in Humans
Circulation, August 9, 2005; 112(6): 789 - 797.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. S. Healey, A. Baranchuk, E. Crystal, C. A. Morillo, M. Garfinkle, S. Yusuf, and S. J. Connolly
Prevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Meta-Analysis
J. Am. Coll. Cardiol., June 7, 2005; 45(11): 1832 - 1839.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. J. Scherlag, W. Yamanashi, U. Patel, R. Lazzara, and W. M. Jackman
Autonomically Induced Conversion of Pulmonary Vein Focal Firing Into Atrial Fibrillation
J. Am. Coll. Cardiol., June 7, 2005; 45(11): 1878 - 1886.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. P. Anyukhovsky, E. A. Sosunov, P. Chandra, T. S. Rosen, P. A. Boyden, P. Danilo Jr., and M. R. Rosen
Age-associated changes in electrophysiologic remodeling: a potential contributor to initiation of atrial fibrillation
Cardiovasc Res, May 1, 2005; 66(2): 353 - 363.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Qu, G. Baroudi, Y. Yue, N. El-Sherif, and M. Boutjdir
Localization and modulation of {alpha}1D (Cav1.3) L-type Ca channel by protein kinase A
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2123 - H2130.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. A. Vest, X. H.T. Wehrens, S. R. Reiken, S. E. Lehnart, D. Dobrev, P. Chandra, P. Danilo, U. Ravens, M. R. Rosen, and A. R. Marks
Defective Cardiac Ryanodine Receptor Regulation During Atrial Fibrillation
Circulation, April 26, 2005; 111(16): 2025 - 2032.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. V. Silva, S. Litovsky, J. A.R. Assad, A. L.S. Sousa, B. J. Martin, D. Vela, S. C. Coulter, J. Lin, J. Ober, W. K. Vaughn, et al.
Mesenchymal Stem Cells Differentiate into an Endothelial Phenotype, Enhance Vascular Density, and Improve Heart Function in a Canine Chronic Ischemia Model
Circulation, January 18, 2005; 111(2): 150 - 156.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
S. G. Williams, D. T. Connelly, M. Jackson, A. Bennett, K. Albouaini, and D. M. Todd
Does treatment with ACE inhibitors or angiotensin II receptor antagonists prevent atrial fibrillation after dual chamber pacemaker implantation?
Europace, January 1, 2005; 7(6): 554 - 559.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C.-C. Lin, J.-L. Lin, C.-S. Lin, M.-C. Tsai, M.-J. Su, L.-P. Lai, and S. K. S. Huang
Activation of the Calcineurin-Nuclear Factor of Activated T-Cell Signal Transduction Pathway in Atrial Fibrillation
Chest, December 1, 2004; 126(6): 1926 - 1932.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Lazar, S. Dixit, F. E. Marchlinski, D. J. Callans, and E. P. Gerstenfeld
Presence of Left-to-Right Atrial Frequency Gradient in Paroxysmal but Not Persistent Atrial Fibrillation in Humans
Circulation, November 16, 2004; 110(20): 3181 - 3186.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Shiroshita-Takeshita, G. Schram, J. Lavoie, and S. Nattel
Effect of Simvastatin and Antioxidant Vitamins on Atrial Fibrillation Promotion by Atrial-Tachycardia Remodeling in Dogs
Circulation, October 19, 2004; 110(16): 2313 - 2319.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
G. D. Veenhuyzen, C. S. Simpson, and H. Abdollah
Atrial fibrillation
Can. Med. Assoc. J., September 28, 2004; 171(7): 755 - 760.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. J.J. Wellens
Cardiac arrhythmias: The quest for a cure: A historical perspective
J. Am. Coll. Cardiol., September 15, 2004; 44(6): 1155 - 1163.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Taneja, G. Horvath, D. K. Racker, D. Johnson, J. Goldberger, and A. Kadish
Is there a correlation between ventricular fibrillation cycle length and electrophysiological and anatomic properties of the canine left ventricle?
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H823 - H832.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Verheule, E. Wilson, S. Banthia, T. H. Everett IV, S. Shanbhag, H. J. Sih, and J. Olgin
Direction-dependent conduction abnormalities in a canine model of atrial fibrillation due to chronic atrial dilatation
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H634 - H644.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Haissaguerre, P. Sanders, M. Hocini, L.-F. Hsu, D. C. Shah, C. Scavee, Y. Takahashi, M. Rotter, J.-L. Pasquie, S. Garrigue, et al.
Changes in Atrial Fibrillation Cycle Length and Inducibility During Catheter Ablation and Their Relation to Outcome
Circulation, June 22, 2004; 109(24): 3007 - 3013.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Verheule, T. Sato, T. Everett IV, S. K. Engle, D. Otten, M. Rubart-von der Lohe, H. O. Nakajima, H. Nakajima, L. J. Field, and J. E. Olgin
Increased Vulnerability to Atrial Fibrillation in Transgenic Mice With Selective Atrial Fibrosis Caused by Overexpression of TGF-{beta}1
Circ. Res., June 11, 2004; 94(11): 1458 - 1465.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. G. de Lima, R. A. K. Kalil, T. L. L. Leiria, D. M. Hatem, C. L. Kruse, R. Abrahao, J. R. M. Sant'anna, P. R. Prates, and I. A. Nesralla
Randomized study of surgery for patients with permanent atrial fibrillation as a result of mitral valve disease
Ann. Thorac. Surg., June 1, 2004; 77(6): 2089 - 2094.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. M. Park, C.-C. Chou, P. C. Drury, Y. Okuyama, A. Peter, A. Hamabe, Y. Miyauchi, R. M. Kass, H. S. Karagueuzian, M. C. Fishbein, et al.
Thoracic vein ablation terminates chronic atrial fibrillation in dogs
Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2072 - H2077.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. H. Everett IV, S. Verheule, E. E. Wilson, S. Foreman, and J. E. Olgin
Left atrial dilatation resulting from chronic mitral regurgitation decreases spatiotemporal organization of atrial fibrillation in left atrium
Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2452 - H2460.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. M. Todd, S. P. Fynn, A. P. Walden, W. J. Hobbs, S. Arya, and C. J. Garratt
Repetitive 4-Week Periods of Atrial Electrical Remodeling Promote Stability of Atrial Fibrillation: Time Course of a Second Factor Involved in the Self-Perpetuation of Atrial Fibrillation
Circulation, March 23, 2004; 109(11): 1434 - 1439.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Nakano, S. Niida, K. Dote, S. Takenaka, H. Hirao, F. Miura, M. Ishida, T. Shingu, T. Sueda, M. Yoshizumi, et al.
Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation
J. Am. Coll. Cardiol., March 3, 2004; 43(5): 818 - 825.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
P. Spurrell, K. Kamalvand, M. Higson, and N. Sulke
Temporal changes in atrial refractoriness following DC cardioversion of persistent atrial fibrillation in man
Europace, January 1, 2004; 6(3): 229 - 235.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. M. Todd, A. C. Skanes, G. Guiraudon, C. Guiraudon, A. D. Krahn, R. Yee, and G. J. Klein
Role of the Posterior Left Atrium and Pulmonary Veins in Human Lone Atrial Fibrillation: Electrophysiological and Pathological Data From Patients Undergoing Atrial Fibrillation Surgery
Circulation, December 23, 2003; 108(25): 3108 - 3114.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Chandra, T. S Rosen, B. Herweg, P. Danilo Jr., and M. R Rosen
Left atrial pacing induces memory and is associated with atrial tachyarrhythmias
Cardiovasc Res, November 1, 2003; 60(2): 307 - 314.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H.-M. Lo, F.-Y. Lin, and Y. Z. Tseng
Atrial compartment operation for atrial fibrillation: to isolate the left atrium or not?
Ann. Thorac. Surg., October 1, 2003; 76(4): 1259 - 1263.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. Dun, P. Chandra, P. Danilo Jr., M. R. Rosen, and P. A. Boyden
Chronic atrial fibrillation does not further decrease outward currents. It increases them.
Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1378 - H1384.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. C. Sanguinetti and P. B. Bennett
Antiarrhythmic Drug Target Choices and Screening
Circ. Res., September 19, 2003; 93(6): 491 - 499.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. R Ehrlich, T.-J. Cha, L. Zhang, D. Chartier, P. Melnyk, S. H Hohnloser, and S. Nattel
Cellular electrophysiology of canine pulmonary vein cardiomyocytes: action potential and ionic current properties
J. Physiol., September 15, 2003; 551(3): 801 - 813.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
G.L. Botto, M. Luzi, and A. Sagone
Atrial fibrillation: the remodelling phenomenon
Eur. Heart J. Suppl., September 1, 2003; 5(suppl_H): H1 - H7.
[Abstract] [PDF]


Home page
CirculationHome page
S. Verheule, E. Wilson, T. Everett IV, S. Shanbhag, C. Golden, and J. Olgin
Alterations in Atrial Electrophysiology and Tissue Structure in a Canine Model of Chronic Atrial Dilatation Due to Mitral Regurgitation
Circulation, May 27, 2003; 107(20): 2615 - 2622.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Ausma, H. M.W. van der Velden, M.-H. Lenders, E. P. van Ankeren, H. J. Jongsma, F. C.S. Ramaekers, M. Borgers, and M. A. Allessie
Reverse Structural and Gap-Junctional Remodeling After Prolonged Atrial Fibrillation in the Goat
Circulation, April 22, 2003; 107(15): 2051 - 2058.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
L.-P. Lai, C.-C. Tsai, M.-J. Su, J.-L. Lin, Y.-S. Chen, Y.-Z. Tseng, and S. K. S. Huang
Atrial Fibrillation Is Associated With Accumulation of Aging-Related Common Type Mitochondrial DNA Deletion Mutation in Human Atrial Tissue
Chest, February 1, 2003; 123(2): 539 - 544.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
N. Colangelo, S. Benussi, S. Nascimbene, S. Calvi, A. Caldarola, G. Piazza, A. Castiglioni, J. Q. Melo, and O. Alfieri
Cardiopulmonary bypass strategy during concomitant surgical treatment of mitral valve disease and atrial fibrillation
Perfusion, January 1, 2003; 18(1): 19 - 24.
[Abstract] [PDF]


Home page
EuropaceHome page
N. Sulke, P. Spurrell, K. Kamalvand, A. Mitchell, M. Higson, J. Gill, and V. Paul
The effect of endocardial defibrillator shocks on basic atrial electrophysiology in man: Is post cardioversion atrial electrical 'remodelling' artefact?
Europace, January 1, 2003; 5(1): 33 - 37.
[Abstract] [PDF]


Home page
EuropaceHome page
R. Mantovan, M. A. Gatzoulis, A. Pedrocco, P. Ius, C. Cavallini, A. De Leo, R. Zecchel, V. Calzolari, C. Valfre, and P. Stritoni
Supraventricular arrhythmia before and after surgical closure of atrial septal defects: spectrum, prognosis and management
Europace, January 1, 2003; 5(2): 133 - 138.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
T. H. Everett IV, J. G. Akar, L.-C. Kok, J. R. Moorman, and D. E. Haines
Use of global atrial fibrillation organization to optimize the success of burst pace termination
J. Am. Coll. Cardiol., November 20, 2002; 40(10): 1831 - 1840.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
E. Bertaglia, D. D'Este, F. Zerbo, F. Zoppo, P. Delise, and P. Pascotto
Success of serial external electrical cardioversion of persistent atrial fibrillation in maintaining sinus rhythm. A randomized study
Eur. Heart J., October 1, 2002; 23(19): 1522 - 1528.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Zhou, C.-M. Chang, T.-J. Wu, Y. Miyauchi, Y. Okuyama, A. M. Park, A. Hamabe, C. Omichi, H. Hayashi, L. A. Brodsky, et al.
Nonreentrant focal activations in pulmonary veins in canine model of sustained atrial fibrillation
Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H1244 - H1252.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Verheule, E. E Wilson, R. Arora, S. K Engle, L. R Scott, and J. E Olgin
Tissue structure and connexin expression of canine pulmonary veins
Cardiovasc Res, September 1, 2002; 55(4): 727 - 738.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Goette, M. Arndt, C. Rocken, T. Staack, R. Bechtloff, D. Reinhold, C. Huth, S. Ansorge, H. U. Klein, and U. Lendeckel
Calpains and cytokines in fibrillating human atria
Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H264 - H272.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
O. Berenfeld, A. V. Zaitsev, S. F. Mironov, A. M. Pertsov, and J. Jalife
Frequency-Dependent Breakdown of Wave Propagation Into Fibrillatory Conduction Across the Pectinate Muscle Network in the Isolated Sheep Right Atrium
Circ. Res., June 14, 2002; 90(11): 1173 - 1180.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Fan, K. L. Lee, W.-H. Chow, E. Chau, and C.-P. Lau
Internal Cardioversion of Chronic Atrial Fibrillation During Percutaneous Mitral Commissurotomy: Insight Into Reversal of Chronic Stretch-Induced Atrial Remodeling
Circulation, June 11, 2002; 105(23): 2746 - 2752.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
K. Oahara, Y. Miyauchi, T. Ohara, M. C. Fishbein, S. Zhou, M.-H. Lee, W. J. Mandel, P.-S. Chen, and H. S. Karagueuzian
Downregulation of Immunodetectable Atrial Connexin4O in a Canine Model of Chronic Left Ventricular Myocardial Infarction: Implications to Atrial Fibrillation
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2002; 7(2): 89 - 94.
[Abstract] [PDF]


Home page
Circ. Res.Home page
G. Schram, M. Pourrier, P. Melnyk, and S. Nattel
Differential Distribution of Cardiac Ion Channel Expression as a Basis for Regional Specialization in Electrical Function
Circ. Res., May 17, 2002; 90(9): 939 - 950.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Kneller, R. Zou, E. J. Vigmond, Z. Wang, L. J. Leon, and S. Nattel
Cholinergic Atrial Fibrillation in a Computer Model of a Two-Dimensional Sheet of Canine Atrial Cells With Realistic Ionic Properties
Circ. Res., May 17, 2002; 90 (9): e73 - e87.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Jalife, O. Berenfeld, and M. Mansour
Mother rotors and fibrillatory conduction: a mechanism of atrial fibrillation
Cardiovasc Res, May 1, 2002; 54(2): 204 - 216.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Allessie, J. Ausma, and U. Schotten
Electrical, contractile and structural remodeling during atrial fibrillation
Cardiovasc Res, May 1, 2002; 54(2): 230 - 246.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Goette, U. Lendeckel, and H. U Klein
Signal transduction systems and atrial fibrillation
Cardiovasc Res, May 1, 2002; 54(2): 247 - 258.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. E. Olgin and S. Verheule
Transgenic and knockout mouse models of atrial arrhythmias
Cardiovasc Res, May 1, 2002; 54(2): 280 - 286.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P.-S. Chen, T.-J. Wu, C. Hwang, S. Zhou, Y. Okuyama, A. Hamabe, Y. Miyauchi, C.-M. Chang, L. S. Chen, M. C. Fishbein, et al.
Thoracic veins and the mechanisms of non-paroxysmal atrial fibrillation
Cardiovasc Res, May 1, 2002; 54(2): 295 - 301.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. J.J.M. Brundel, R. H. Henning, H. H. Kampinga, I. C. Van Gelder, and H. J.G.M. Crijns
Molecular mechanisms of remodeling in human atrial fibrillation
Cardiovasc Res, May 1, 2002; 54(2): 315 - 324.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morillo, C. A.
Right arrow Articles by Guiraudon, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morillo, C. A.
Right arrow Articles by Guiraudon, C. M.